rs76175818

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_021619.3(PRDM12):​c.855G>A​(p.Thr285Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000776 in 1,600,044 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0011 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 24 hom. )

Consequence

PRDM12
NM_021619.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0440

Publications

1 publications found
Variant links:
Genes affected
PRDM12 (HGNC:13997): (PR/SET domain 12) This gene encodes a transcriptional regulator of sensory neuronal specification that plays a critical role in pain perception. The encoded protein contains an N-terminal PRDI-BF1 and RIZ homology (PR) domain, a SET domain, and three C-terminal C2H2 zinc finger DNA-binding domains. Naturally occurring mutations in this gene are associated with congenital insensitivity to pain (CIP), and hereditary sensory and autonomic neuropathies (HSAN's) affecting peripheral sensory and autonomic neurons. Deregulation of this gene is associated with solid cancers and hematological malignancies including chronic myeloid leukaemia. [provided by RefSeq, Mar 2017]
PRDM12 Gene-Disease associations (from GenCC):
  • congenital insensitivity to pain-hypohidrosis syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • hereditary sensory and autonomic neuropathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 9-130681420-G-A is Benign according to our data. Variant chr9-130681420-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475817.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.044 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00108 (165/152186) while in subpopulation EAS AF = 0.029 (150/5172). AF 95% confidence interval is 0.0252. There are 1 homozygotes in GnomAd4. There are 92 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRDM12NM_021619.3 linkc.855G>A p.Thr285Thr synonymous_variant Exon 5 of 5 ENST00000253008.3 NP_067632.2 Q9H4Q4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRDM12ENST00000253008.3 linkc.855G>A p.Thr285Thr synonymous_variant Exon 5 of 5 1 NM_021619.3 ENSP00000253008.2 Q9H4Q4
PRDM12ENST00000676323.1 linkc.855G>A p.Thr285Thr synonymous_variant Exon 5 of 6 ENSP00000502471.1 A0A6Q8PH01

Frequencies

GnomAD3 genomes
AF:
0.00108
AC:
164
AN:
152076
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0289
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.00244
AC:
551
AN:
225496
AF XY:
0.00206
show subpopulations
Gnomad AFR exome
AF:
0.000154
Gnomad AMR exome
AF:
0.0000302
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0316
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000987
Gnomad OTH exome
AF:
0.00161
GnomAD4 exome
AF:
0.000743
AC:
1076
AN:
1447858
Hom.:
24
Cov.:
31
AF XY:
0.000691
AC XY:
498
AN XY:
720280
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32434
American (AMR)
AF:
0.0000905
AC:
4
AN:
44206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25926
East Asian (EAS)
AF:
0.0255
AC:
998
AN:
39080
South Asian (SAS)
AF:
0.0000236
AC:
2
AN:
84676
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48004
Middle Eastern (MID)
AF:
0.000188
AC:
1
AN:
5326
European-Non Finnish (NFE)
AF:
0.00000902
AC:
10
AN:
1108316
Other (OTH)
AF:
0.00102
AC:
61
AN:
59890
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00108
AC:
165
AN:
152186
Hom.:
1
Cov.:
32
AF XY:
0.00124
AC XY:
92
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0000963
AC:
4
AN:
41554
American (AMR)
AF:
0.000458
AC:
7
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0290
AC:
150
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67958
Other (OTH)
AF:
0.00142
AC:
3
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000521
Hom.:
0
Bravo
AF:
0.00105
Asia WGS
AF:
0.00347
AC:
12
AN:
3476

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital insensitivity to pain-hypohidrosis syndrome Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 11, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Mar 24, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.40
CADD
Benign
13
DANN
Benign
0.96
PhyloP100
0.044
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76175818; hg19: chr9-133556807; API